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Objective: Hypopituitarism diagnosed in childhood, adolescence and young adulthood has the potential to affect growth and somatic development.  Less is known about the impact of such a diagnosis on other aspects of development. 
Design: An analysis of the KIMS Database (Pfizer International Metabolic Database) was performed to explore social, educational and vocational outcomes of adult patients diagnosed in childhood, adolescence and young adulthood compared with adult-onset controls.
Patients: 2878 adult patients diagnosed with hypothalamic pituitary conditions before the age of 25 were divided into 2 groups: childhood-onset [<16 years (CO)] (n= 1735) and young-adult-onset [16-<25years (YAO)] (n=1143).  1617 adult patients diagnosed with a non functioning pituitary adenoma at the age of 25 or older formed the adult-onset control group (AO).  
Measurements: KIMS Patient Life Situation Form which provided information on: social, educational and vocational outcomes. 
Results: Compared with AO controls CO and YAO patients were between 4.5 and 8.0 times more likely to live with their parents in adulthood, CO and YAO patients were also less likely to live in partnership and to have children. The impact on educational and vocational outcomes was less marked than on social outcomes with no significant differences compared with AO controls.  Educational and vocational outcomes showed the lowest level in male and female CO and YAO patients who had been previously diagnosed with a brain tumour.





Growing up with hypopituitarism through adolescence and young adulthood has the potential to affect physical, psychological and social development as well as interrupting educational and vocational trajectories of the young person.  Physical development has been well studied, focussing on outcomes of adult height1 and somatic development2, which are known to be affected by hypopituitarism and in particular growth hormone deficiency (GHD). Less is known about the achievement of the five milestones associated with entering adulthood including completing school/education, beginning one’s professional career, leaving home, building a stable relationship and becoming a parent.  Achieving these milestones is of significant importance to the development of an adult identity, quality of life, emotional adjustment and functioning in society. 
A recent study examining social, educational and vocational outcomes in young people with long term conditions identified 4 distinct patterns, 1) those that developed normally, 2) those that achieved educational and vocational goals but underperformed socially, 3) those that despite poor achievement in education and vocation were able to succeed socially and 4) slow developers who  underperformed in education, vocation and social arenas3.  
Previous studies have focused on hypothalamic pituitary conditions with GHD of childhood-onset (CO)4-12,  ADDIN EN.CITE  but have not examined the impact of being diagnosed in late adolescence and young adulthood, a key time for focusing on education and vocation and also for social change. The aim of this study is therefore to explore the social, educational and vocational outcomes of patients with hypothalamic-pituitary conditions with GHD diagnosed in childhood (<16 years) and late adolescence and young adulthood (16-<25 years). 
Subjects & Methods
Subjects
This was a retrospective analysis of data from hypopituitary adults with GH deficiency (GHD) obtained from KIMS (Pfizer International Metabolic Database) who were enrolled between 1994 and October 2011.  15 725 patients from 31 countries were included in the database at the cut-off point. The KIMS database was searched to identify patients who had been diagnosed with a hypothalamic pituitary conditions or a condition that results in hypothalamic pituitary dysfunction before the age of 25 and who had completed the KIMS Patient Life Situation Form (KIMS PLSF). The KIMS Database was approved by the Institutional Review Boards, as required by local regulations in each participating country. All patients were informed about the study and consent was gained in written form for their participation. KIMS is conducted according to the Declaration of Helsinki (12). 
Patients were divided into 2 groups by age of diagnosis: CO <16 years and Young-Adult-Onset (YAO) 16-<25 years. In the CO and YAO groups patients were included if they had a non-acquired diagnosis including congenital and idiopathic causes (NA) or a diagnosis of a craniopharyngioma (CP), pituitary adenoma (PA), brain tumour (BT) or haematological malignancy (HM).  Adult-onset (AO) patients diagnosed with a non-functioning pituitary adenoma (NFPA) at the age of 25 or older, and who had completed the KIMS PLSF formed the control group as they represent the largest AO control group included in the KIMS Database. 
KIMS Patient Life Situation Form
The KIMS PLSF is a patient-reported outcome questionnaire, given to the patient in clinic for self- completion, asking questions about personal and social situations including education and vocation (13). Types of employment are described as white collar to mean professional, managerial or administrative as opposed to blue collar which means manual labour.
Statistical Analysis
Data from individual patients were analysed in 3 age bands (25-35, 35-45, 45-55 years), using data closest to the middle of each age band (a patient can be represented in more than one age band but only once in each age band).  Percentages of patients achieving each outcome were calculated. CO and YAO patients were compared as a whole group and by diagnostic category with the AO control group using Fisher Exact Test. Different diagnostic groups were compared using least mean squares. Taking the percentage of the equivalent AO control group as equalling 1, fold differences were calculated for the 35-45 age band only.  This age band was chosen due to the largest numbers across CO (n=513), YAO (n=404) and AO (n=487) groups and also represents an age at least 10 years or longer after diagnosis for CO and YAO patients and by which most outcomes are anticipated to have been completed.
Forward stepwise linear regression was performed on the last available KIMS PLSF in each patient in the CO and YAO groups to identify factors influencing each outcome.  Variables included current age, gender, diagnosis, age and calendar year at diagnosis of the hypothalamic pituitary condition or the condition that results in hypothalamic pituitary dysfunction, treatment factors (radiotherapy (XRT) and surgery), number of additional pituitary hormone deficiencies and adult height SDS. Age and gender corrected height expressed as a Standard Deviation Score (SDS) from the mean height of a normal population was calculated. SDS: 0=Normal height, -2SDS=Shorter than 2.5% of the population, +2SDS=Taller than 97.5% of the population.
Statistical procedures were conducted using the Statistical Analysis System (SAS Institute, Inc, Cary, NC). Statistical significance was taken as p<0.05 (Fisher Exact Test and forward stepwise regression) and p<0.01 (Least Mean Squares) due to multiple comparisons.
Results
2878 patients diagnosed before the age of 25 were identified in the KIMS database; 1735 childhood-onset [<16 years (CO)] and 1143 young-adult-onset [16-<25years (YAO)] patients.  The control group compromises of 1617 AO NFPA patients. The patients come from 27 countries with the largest contribution from UK (n=1071) followed by Germany (n=994) and Sweden (n=688). Belgium, the Netherlands, Spain, France, Czech Republic and Denmark all contributed more than 100 patients. 
CO and YAO patients divided by diagnosis and AO group characteristics are presented in Table 1. 
SOCIAL OUTCOMES - LIVING WITH PARENTS & LIVING IN PARTNERSHIP AND HAVING CHILDREN
In the group as a whole regardless of age band and diagnostic group in adulthood CO and YAO groups were more likely to live with their parents than AO NFPA controls. At the age of 35 to 45 CO and YAO groups were four times more likely to live with their parents, while CO females were eight times more likely to live with their parents in adulthood (Table 2).  Some differences were seen between diagnostic groups: CO females with craniopharyngiomas were more likely to live with their parents compared with those with pituitary adenomas and non acquired diagnoses ; YAO males with brain tumours were more likely to live with their parents compared with those with pituitary adenomas (Figure 1).
In the group as a whole regardless of age band and diagnostic group CO and YAO groups were less likely to live in partnership and have children than AO controls. At the age of 35 to 45 in CO groups around half the numbers, expected based on levels observed in AO controls, lived in partnership and only a third to a quarter had children, and in YAO groups around two thirds to three quarters of the numbers expected lived in partnership and over half had children (Table 2).  The only difference observed between diagnostic groups was in CO females with brain tumours who were less likely to have children than CO females with a non acquired diagnosis. 
The results of forward stepwise regression adjusted for age showed that in the combined CO and YAO groups, patients with fewer pituitary hormone deficiencies and of taller stature were less likely to live with their parent while patients with the diagnosis of a pituitary adenoma were more likely to live in partnership and have children. Female patients were less likely to live with their parents and more likely to live in partnership. A diagnosis of a brain tumour was associated with living with their parents, and not having undergone radiotherapy was associated with living in partnership. A later calendar year at diagnosis was associated with improved social outcomes (Table 3).
EDUCATIONAL AND VOCATIONAL OUTCOMES - HIGHER EDUCATION & BEING IN EDUCATION, EMPLOYMENT OR TRAINING (EET)
In the whole group no differences were found for completing higher education or being in EET compared with AO NFPA controls (Table 2). Females with brain tumours had lower levels of being in EET than AO controls. CO female brain tumour patients had significantly lower levels of being in EET than CO patients with non acquired diagnoses or craniopharyngiomas (Figure 1).
Analysis by forward stepwise regression identified that being of taller stature, a fewer number of pituitary hormone deficiencies, and a later year at diagnosis were associated with having received higher education.   Being in EET was associated with a later year at diagnosis and not having the diagnosis of a brain tumour, being male and not having radiotherapy (Table 3).  The factors associated with being in full time employment rather than part time were being male, not having a brain tumour, having a pituitary adenoma and not having had radiotherapy.  Those in white collar work rather than blue collar work were older age at diagnosis, were more often females, having had radiotherapy and not having a brain tumour (Table 3).  
Discussion
Patients diagnosed with hypothalamic pituitary conditions before the age of 25 are failing to successfully achieve the social outcomes of adult life.  Although CO patients are more markedly affected, YAO patients also have significantly decreased social outcomes even at the ages of 35 to 45 years across a range of diagnoses.  This remains true for YAO patients diagnosed with pituitary adenomas, potentially the group with a closer match to the control group of AO patients with NFPA, suggesting it is the age of onset rather than the disease process that is implicated in reduced outcomes. Educational and vocational outcomes are less affected in comparison.  
This study confirms the finding of other studies that CO patients with hypopituitarism are adversely affected in respect to achieving their social outcomes (3,4,6,7,9).  A meta-analysis of studies examining similar outcomes in 25 year old patients with different CO long term conditions compared with healthy peers found a similar level for living in partnership, but higher levels of leaving home compared with this current study (22% living with parents compared with 33-37% in this study) and in having children  (38% having children compared with 9% in this study) (14). This suggests that CO patients with hypopituitarism with GHD are among the long term conditions most adversely affected with regards to social outcomes.  The current study now demonstrates that YAO patients diagnosed with hypopituitarism have also not avoided the social consequences.  This is despite a shorter duration of disease, potentially starting at a time when social trajectories had already been set.  
The reasons for patients with hypopituitarism failing to achieve social outcomes are likely to be multifactorial and similar to those faced by others growing up with a long term condition.  Patients with hypopituitarism may experience difficulties in self-confidence and the ability to socialise with their peer group, which can all hinder the chances of living independently, living with a partner and having children. In a range of long term conditions limitations in functional ability and participation in social activities, as well as absenteeism from school, university/college, or workplace may negatively affect the achievement of these milestones (15). Lesser academic achievement, lower employment, and delayed independence may also result from an alteration in an individual’s life goals, for example, when having to invest a lot of time in illness management (16). In addition, negative attitudes toward individuals with chronic illness or disabilities may contribute to their lower success in mastering tasks associated with adult life (17). There is evidence of discrimination against individuals with chronic illness and disability when applying for a job and in the workplace in general (18). In addition, parents of young people with chronic physical illness are, on average, more overprotective than other parents (14). This may inhibit the development of an independent life in adulthood. Furthermore, illness-specific reasons may play a role, such as reduced fertility due to gonadotrophin deficiency and/or ovarian damage secondary to chemotherapy and/or radiotherapy.  
This current study found minimal differences in level of education and also employment, with differences being confined to certain diagnostic groups or being specific to gender, for example, females with brain tumours had lower levels of being in education, employment and training (EET). A study from Denmark identified a lower education level, lower income and higher risk of retirement (6) and the meta-analysis across a range of long term conditions identified a 25% reduction in employment (14).  This lack of difference is potentially explained by our control group having been born earlier when opportunities for training and employment may have been lower and also having a long term condition which is known to have reduced employment. More detailed analysis such as income may have yielded differences as in previous studies. The group that was adversely affected were those with brain tumours regardless of age of onset and particularly females, who were less likely to be in EET.  This has been previously shown and is likely to be due in part to the neurocognitive sequelae as a direct consequence of having a brain tumour and intensity of cancer treatment including radiotherapy (19–21).       
In contrast with the study from Denmark (6), our study, analysing  larger numbers of patients, found little difference across the diagnoses. This is likely to reflect how study populations were selected; this current study using a disease database of patients starting on GH replacement in adulthood  potentially reflects patients most affected, rather than a population based study (6).  It also suggests that patients across diagnoses with persistent GHD into adulthood are at similar levels of risk in not achieving outcomes. 
The number of pituitary hormone deficits and adult height was an associated factor across social, educational and vocational outcomes, in particular, in living with parents and not having higher education. Both reflect the health burden of the condition and also potentially the visibility and the real or perceived need for ongoing involvement of parents.  Previous studies have identified an association with degree of hypopituitarism and psychosocial outcome (10).  The effect of height has been extensively studied with short stature in either health or illness being predominantly reported in males with poorer outcomes throughout the lifespan (7,10). 
The later year of diagnosis Being diagnosed more recently had a positive impact on all outcomes but particularly EET which may reflect improved medical care and/or support provided in education. This was also identified in the meta-analysis, later publications had less reduction in income compared with healthy peers (14).
When interpreting these data it is important to recognise that patients in the KIMS database potentially represent the more severely affected patients with hypopituitarism and GHD and reduced quality of life.  The control group, AO patients with NFPA, identified from the same database, also have a long term condition, and therefore if patients had been compared with healthy peers the deficits would potentially have been greater.  The advantages of this approach include similarities in data collection using the same tool and the fact that the control group is representative of patients attending the same clinics as the CO and YAO patients.  The disadvantages are that the control group was not matched for year of birth and on average were born 10-15 years earlier than the CO and YAO cohort,  resulting in different trends regarding living with parents, education, employment and training.  
In summary, children, adolescents and young adults diagnosed with hypopituitarism persistent into adulthood are failing to achieve their social outcomes.  This remains true for YAO patients including those diagnosed with pituitary adenomas.  Although social, educational and vocational outcomes are both recognised as important determinants of long term health, as shown in this study, there is more of a focus on making young people employable and economically active than helping with social skills and opportunity for peer interaction.  This is despite social relationships being shown to be particularly important in increasing resilience and promoting recovery. A previous study in CO patients with GHD demonstrated a reduction in likelihood of death once socioeconomic factors were adjusted for (6). Holistic endocrine care across paediatric and adult services should support increasing independence in all aspects of life and peer interaction to reduce the barriers to adjusting to adult life.
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